CMS Warned About Unintended Consequences of Part B Drug Proposal

May 12—In March, the Centers for Medicare & Medicaid Services (CMS) released a proposal to test new payment methodologies for Medicare Part B drugs and called it part of “a strategy to encourage better care, smarter spending, and healthier people.”